ALTO Reauthorization Act of 2021

Bill: 117-s-2538
Sponsor: full_name: Sen. Booker, Cory A. [D-NJ]
Introduced: 2021-07-29
Policy area: Health
Latest action: action_date: 2021-07-29
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2021-07-29
action_desc: Introduced in Senate
text: <p><strong>Alternatives to Opioids in the Emergency Department Reauthorization Act of 2021 or the ALTO Reauthorization Act of 2021</strong></p> <p>This bill reauthorizes through FY2026 a grant program for developing and implementing alternatives to opioids for pain management in hospitals and emergency departments.</p>

tv_txt: II 117th CONGRESS 1st Session S. 2538 IN THE SENATE OF THE UNITED STATES July 29, 2021 Mr. Booker (for himself and Mrs. Capito ) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To reauthorize a program of grants to hospitals and emergency departments to develop, implement, enhance, or study alternatives to opioids for pain management, and for other purposes.

1. Short title This Act may be cited as the Alternatives to Opioids in the Emergency Department Reauthorization Act of 2021 or the ALTO Reauthorization Act of 2021 . 2. Reauthorization of emergency alternatives to opioids program Section 7091 of the SUPPORT for Patients and Communities Act ( 42 U.S.C. 294i note) is amended— (1) in the section heading, by striking demonstration ; (2) in the headings of subsections (a) and (b), by striking demonstration each place it appears; (3) in subsections (a)(1) and (b), by striking demonstration each place it appears; (4) in subsection (f)— (A) by striking Not later than 1 year after completion of the demonstration program under this section and inserting Not later than the end of each of calendar years 2022 and 2028 ; and (B) by striking demonstration after results of the ; and (5) in subsection (g), by striking 2019 through 2021 and inserting 2022 through 2026 .